Organization | Ospedale San Raffaele

Ospedale San Raffaele Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2015

NCT02542852

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Alberto Briganti | Emanuele Bosi | Giorgio Gandalgia | Michele Reni | Prof. Massimo Filippi | Scarlata, Simone, M.D. | Vito Cucchiara

Active Ingredients

Drugs in Phase 2 Trials (5)

atazanavir (reyataz) (1 trial)

chlorambucil (Leukeran) (1 trial)

dolutegravir (tivicay) (1 trial)

interferon beta-1a (Avonex) (1 trial)

ritonavir (Norvir) (1 trial)

Drugs in Other Trials (4)

fentanyl (Innovar) (1 trial)

midazolam (versed) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Viremia (Phase 2)

Virus Diseases (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 9